| Date Filed | Type | Description |
| 07/13/2023 |
4
| KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Paid exercise price by delivering 3,216 shares
@ $0.5903, valued at
$1.9k
Exercised 13,204 restricted stock units
@ $0 |
|
| 07/05/2023 |
4
| KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Paid exercise price by delivering 3,584 shares
@ $0.5788, valued at
$2.1k
Exercised 14,717 restricted stock units
@ $0 |
|
| 11/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/15/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/15/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/12/2021 |
4
| KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Paid exercise price by delivering 3,215 shares
@ $3.56, valued at
$11.4k
Exercised 13,205 restricted stock units
@ $0 |
|
| 07/06/2021 |
4
| KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Paid exercise price by delivering 3,584 shares
@ $3.56, valued at
$12.8k
Exercised 14,718 restricted stock units
@ $0 |
|
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/15/2019 |
4/A
| KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Granted 500,000 options to buy
@ $1.82, valued at
$910k
|
|
| 07/15/2019 |
4
| KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Granted 500,000 options to buy
@ $1.31, valued at
$655k
Granted 316,907 restricted stock units
@ $0 |
|
| 07/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2019 |
3
| KLEMP WALTER V (Director) has filed a Form 3 on Soliton, Inc. |
| 06/08/2018 |
4
| KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Granted 603,000 options to buy
@ $1.82, valued at
$1.1M
|
|
| 08/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/07/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |